Skip to main content
. 2018 Jul 27;62(8):e00464-18. doi: 10.1128/AAC.00464-18

TABLE 1.

Characteristics of healthy adult subjects receiving oral fosfomycin tromethamine

Treatment (n) No. (%) of male subjects No. (%) of white subjects Mean ± SD
Age (yr) Ht (cm) Wt (kg) Body mass index (kg/m2) eCLCRa (ml/min)
Oral fosfomycin (18) 9 (50) 13 (72) 28 ± 7 173.2 ± 9.9 75.4 ± 11.5 24.9 ± 2.5 110 ± 19.9
a

eCLCR, Cockroft-Gault estimated creatinine clearance.